IBD and the Microbiome

https://www.youtube.com/watch?v=lJAslH6eZZY Seres Therapeutics, Inc., announced the initiation of two academic research collaborations to further develop the company’s microbiome therapeutics platform as a treatment for inflammatory bowel disease (IBD). Under the agreements, the company will work with teams at the Research Institute of St. Joseph’s Hamilton, Canada, and the Medical University of Graz, Austria. In this NewYork-Presbyterian Hospital video, learn more about how these bacteria may affect the body, especially in inflammatory bowel diseases (IBD) patients with Dr. Randy Longman, physician-researcher at the Center for Advanced Digestive Care (CADC) at NewYork-Presbyterian/Weill Cornell Medical Center. Read the full arti
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *